FDA approved LUMAKRAS for patients with KRAS G12C-mutated locally advanced or metastatic non-small cell lung cancer
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved LUMAKRAS (sotorasib)…
On May 28, 2021, CureVac announced that the independent Data Safety Monitoring Board (DSMB)confirmed that the pivotal Phase…
On May 28, 2021, the University of Oxford announced the launch of a new centre of global research…
On May 28, 2021, Humanigen announced that the company had submitted an application to the FDA requesting Emergency…
On May 28, 2021, Pfizer and BioNTech announced that the Conditional Marketing Authorization for COMIRNATY in the European…
On May 28, 2021, the Oregon Department of Agriculture (ODA) lifted the quarantine on the Oregon mink farm…
On May 28, 2021, Omeros announced preliminary results from the second cohort of critically ill COVID-19 patients treated…
On May 27, 2021, Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase…
On May 27, 2021, Innovation Pharma announced that patient enrollment in the Company’s 120-patient, Phase 2 clinical trial…
On May 27, 2021, Innovation Pharmaceuticals announced that patient enrollment in the Companyï¾’s 120-patient, Phase 2 clinical trial…
On May 27, 2021, Seattle Children’s researchers published a study that uncovered a deeper understanding of why people…
On May 27, 2021, Sanofi and GlaxoSmithKline started enrolment in their Phase 3 clinical study to assess the…
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
On May 26, 2021, Altimmune announced new results from a preclinical study demonstrating the ability of its AdCOVID…
On May 26, 2021, Henry Schein announced the Company was awarded a $53.4 million contract from the U.S….
On May 26, 2021, GlaxoSmithKline and Vir Biotechnology announced the U.S. Food and Drug Administration (FDA) granted an…
On May 26, 2021, the National Center for Biotechnology Information announced a report that aimed to analyze the…
On May 25, 2021, ImmunityBio announced two South African studies to examine the potential for using its hAd5…
On May 25, 2021, Moderna announced that the Phase 2/3 study of its COVID-19 vaccine (mRNA-1273) in adolescents…
Cast of Characters: Donald Trump, President | Mike Pence, Vice President | Anthony S. Fauci, MD, Director, National…
On May 24, 2021, scientists reported that women taking 1,000 mg of docosohexanoic acid (DHA) daily in the…
On May 24, 2021, the World Health Organization (WHO) and the Swiss Confederation signed a Memorandum of Understanding…
On May 24, 2021, Quidel announced that its Sofia’ SARS Antigen FIA was the first rapid antigen test…
On May 24, 2021, Moderna and Aldevron announced their expanded collaboration in support of the Moderna COVID-19 Vaccine…
On May 24, 2021, LabCorp reported that nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2…
On May 24, 2021, Pfizer announced that the first enrolled subjects had received their immunizations as part of…
On May 22, 2021, Moderna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung…
On May 22, 2021, Novavax announced the signing of a non-binding memorandum of understanding (MoU) with the Ministry…
On May 21, 2021, AstraZeneca announced that it had been granted a special approval for emergency use in…
On May 21, 2021, the the U.S. Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) as the first…